Literature DB >> 19154412

Impaired Tax-specific T-cell responses with insufficient control of HTLV-1 in a subgroup of individuals at asymptomatic and smoldering stages.

Yukiko Shimizu1, Ayako Takamori, Atae Utsunomiya, Mayumi Kurimura, Yoshihisa Yamano, Masakatsu Hishizawa, Atsuhiko Hasegawa, Fumiaki Kondo, Kiyoshi Kurihara, Nanae Harashima, Toshiki Watanabe, Jun Okamura, Takao Masuda, Mari Kannagi.   

Abstract

Human T-cell leukemia virus type-1 (HTLV-1)-specific T-cell immunity, a potential antitumor surveillance system in vivo, is impaired in adult T-cell leukemia (ATL). In this study, we aimed to clarify whether the T-cell insufficiency in ATL is present before the disease onset or occurs as a consequence of the disease. We investigated T-cell responses against Tax protein in peripheral blood mononuclear cells (PBMCs) from individuals at earlier stages of HTLV-1-infection, including 21 asymptomatic HTLV-1 carriers (ACs) and four patients with smoldering-type ATL (sATL), whose peripheral lymphocyte count was in normal range. About 30% of samples tested showed clear Tax-specific interferon (IFN)-gamma producing responses. Proviral loads in this group were significantly lower than those in the other less-specific response group. The latter group was further divided to two subgroups with or without emergence of Tax-specific responses following depletion of CC chemokine receptor 4 (CCR4)(+) cells that contained HTLV-1-infected cells. In the PBMCs with Tax-specific responses, CD8(+) cells efficiently suppressed HTLV-1 p19 production in culture. The remaining group without the emergence of Tax-specific response after CCR4(+) cell-depletion included at least two sATL and one AC samples, which spontaneously produced HTLV-1 p19 in culture, where tetramer-binding, Tax-specific cytotoxic T-lymphocytes were either undetectable or unresponsive. Our results indicated that HTLV-1-specific T-cell responsiveness widely differed among HTLV-1 carriers, and that impairment of HTLV-1-specific T-cell responses was observed not only in advanced ATL patients but also in a subpopulation at earlier stages, which was associated with insufficient control of HTLV-1.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19154412     DOI: 10.1111/j.1349-7006.2008.01054.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  7 in total

1.  A Unique T-Cell Receptor Amino Acid Sequence Selected by Human T-Cell Lymphotropic Virus Type 1 Tax301-309-Specific Cytotoxic T Cells in HLA-A24:02-Positive Asymptomatic Carriers and Adult T-Cell Leukemia/Lymphoma Patients.

Authors:  Yuko Ishihara; Yukie Tanaka; Seiichiro Kobayashi; Koji Kawamura; Hideki Nakasone; Ayumi Gomyo; Jin Hayakawa; Masaharu Tamaki; Yu Akahoshi; Naonori Harada; Machiko Kusuda; Kazuaki Kameda; Tomotaka Ugai; Hidenori Wada; Kana Sakamoto; Miki Sato; Kiriko Terasako-Saito; Misato Kikuchi; Shun-Ichi Kimura; Aki Tanihara; Shinichi Kako; Kaoru Uchimaru; Yoshinobu Kanda
Journal:  J Virol       Date:  2017-09-12       Impact factor: 5.103

2.  Functional impairment of Tax-specific but not cytomegalovirus-specific CD8+ T lymphocytes in a minor population of asymptomatic human T-cell leukemia virus type 1-carriers.

Authors:  Ayako Takamori; Atsuhiko Hasegawa; Atae Utsunomiya; Yasuhiro Maeda; Yoshihisa Yamano; Masato Masuda; Yukiko Shimizu; Yotaro Tamai; Amane Sasada; Na Zeng; Ilseung Choi; Naokuni Uike; Jun Okamura; Toshiki Watanabe; Takao Masuda; Mari Kannagi
Journal:  Retrovirology       Date:  2011-12-07       Impact factor: 4.602

Review 3.  Potential Diagnostic, Prognostic and Therapeutic Targets of MicroRNAs in Human Gastric Cancer.

Authors:  Ming-Ming Tsai; Chia-Siu Wang; Chung-Ying Tsai; Hsiang-Wei Huang; Hsiang-Cheng Chi; Yang-Hsiang Lin; Pei-Hsuan Lu; Kwang-Huei Lin
Journal:  Int J Mol Sci       Date:  2016-06-16       Impact factor: 5.923

Review 4.  A role for an HTLV-1 vaccine?

Authors:  Lee Ratner
Journal:  Front Immunol       Date:  2022-09-08       Impact factor: 8.786

5.  In vivo expression of the HBZ gene of HTLV-1 correlates with proviral load, inflammatory markers and disease severity in HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP).

Authors:  Mineki Saito; Toshio Matsuzaki; Yorifumi Satou; Jun-Ichirou Yasunaga; Kousuke Saito; Kimiyoshi Arimura; Masao Matsuoka; Yoshiro Ohara
Journal:  Retrovirology       Date:  2009-02-19       Impact factor: 4.602

6.  Abnormally high levels of virus-infected IFN-gamma+ CCR4+ CD4+ CD25+ T cells in a retrovirus-associated neuroinflammatory disorder.

Authors:  Yoshihisa Yamano; Natsumi Araya; Tomoo Sato; Atae Utsunomiya; Kazuko Azakami; Daisuke Hasegawa; Toshihiko Izumi; Hidetoshi Fujita; Satoko Aratani; Naoko Yagishita; Ryoji Fujii; Kusuki Nishioka; Steven Jacobson; Toshihiro Nakajima
Journal:  PLoS One       Date:  2009-08-05       Impact factor: 3.240

7.  Is There a Role for HTLV-1-Specific CTL in Adult T-Cell Leukemia/Lymphoma?

Authors:  Aileen G Rowan; Charles R M Bangham
Journal:  Leuk Res Treatment       Date:  2011-11-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.